Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Endometrial ablation for heavy menstrual bleeding.

Malcolm G Munro1

  • 1Department of Obstetrics and Gynecology, David Geffen School of Medicine at UCLA, Kaiser Foundation Hospitals, Los Angeles Medical Center, Los Angeles, CA, USA. M.G.Munro@kp.org

Current Opinion in Obstetrics & Gynecology
|June 25, 2005
PubMed
Summary

This review compares resectoscopic endometrial ablation (REA) and nonresectoscopic endometrial ablation (NREA) for heavy menstrual bleeding. Both methods offer alternatives to hysterectomy, with NREA showing potentially fewer complications.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Letter to the editor: Anovulatory bleeding and the spectrum of bleeding disorders: Understanding heavy menstrual bleeding in adolescents.

International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics·2026
Same author

Appraisal of international, patient-facing resources on heavy menstrual bleeding.

International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics·2026
Same author

The effects of endometrial polyps, leiomyomas, adenomyosis, and endometriosis on endometrial receptivity: phenotype, molecular pathways, and clinical implications.

Current opinion in obstetrics & gynecology·2026
Same author

Endometrial Polyps.

Obstetrics and gynecology·2026
Same author

The epidemiology and pathogenesis of uterine fibroids.

International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics·2025
Same author

Understanding Acute Heavy Menstrual Bleeding: Insights From an Interdisciplinary Panel.

O&G open·2025

Area of Science:

  • Gynecology
  • Minimally Invasive Surgery

Background:

  • Heavy menstrual bleeding (HMB) significantly impacts women's quality of life.
  • Hysterectomy is a definitive treatment but carries substantial risks and costs.
  • Endometrial ablation offers a less invasive alternative for HMB management.

Purpose of the Study:

  • To review current evidence comparing resectoscopic endometrial ablation (REA) and nonresectoscopic endometrial ablation (NREA) techniques.
  • To evaluate the efficacy and safety of different endometrial ablation methods for HMB.
  • To identify optimal candidates for endometrial ablation procedures.

Main Methods:

  • Systematic review of available evidence on REA and NREA.
  • Comparison of procedural characteristics, outcomes, and complication rates.

Related Experiment Videos

  • Analysis of long-term follow-up data and repeat surgery rates.
  • Main Results:

    • Laser endometrial ablation is rarely used due to time, cost, and training.
    • REA is versatile for various cavity shapes and considered a gold standard in expert hands.
    • NREA devices offer diverse advantages/disadvantages regarding treatment time, dilation, and cavity suitability.
    • Both REA and NREA yield comparable results to REA in expert hands.
    • NREA may have lower serious complication rates, though uterine perforation and visceral injury are possible.
    • Repeat surgery rates for endometrial ablation range from 20-40% within 5 years.
    • Levonorgestrel-releasing intrauterine devices (IUDs) show similar outcomes to ablation but allow fertility preservation and office insertion.

    Conclusions:

    • REA and NREA provide short- to intermediate-term alternatives to hysterectomy for HMB.
    • Ideal candidates have normal/near-normal cavities and are within 5 years of menopause.
    • Levonorgestrel-IUDs offer comparable outcomes and fertility-sparing benefits.